Reading view
MCP-AI: Protocol-Driven Intelligence Framework for Autonomous Reasoning in Healthcare
The Seeds of Scheming: Weakness of Will in the Building Blocks of Agentic Systems
UK doctorsβ surgeries deploying AI in patient care
InTouchNow.ai is now offering doctors surgeries a piece of software designed to modernise phone answering, designed to reduce hold times and create a smoother, more responsive experience for patients and staff. In the UK, many GP (general practice) surgeriesβ phone lines are tied up in the mornings as patients try to contact their medical practitioner for appointments. More acute need can be delayed among calls with routine enquiries, meaning high-priority callers can be left waiting for long periods.
The system uses voice-based AI to handle calls, schedule appointments, and assess patient needs, and is capable of handling many calls simultaneously, channelling callers with appointment requests, those seeking general advice, prescription requests, and seeking results of clinical tests.
Founded by Daniel Park, InTouchNow.ai draws on his 30+ years of experience in medical call centres. The AI receptionist answers calls quickly, and can automatically update integrated appointment systems. Practices can record a voice messages to personalise the experience for patients.
Benefits for practices include reducing the numbers of missed calls, decreased workload for reception staff, and improved access by patients to medical services. Being entirely software-based, the system operates outside regular hours, which can reduce the need for staff overtime at times of peak demand.
The system integrates with common GP software like Surgery Connect, AWS, and Anima, automating tasks and maintaining patient data security while giving practices full control.
The technology supports over 200 languages, with options for different dialects and accents, an aspect that will help patients in multi-cultural areas like inner-cities. Several practices in the UK are already using InTouchNow.ai and have reported positive results in call handling and patient access.
The much under-funded National Health Service in the UK has been quick to deploy AI-powered software to reduce its operating costs, often targeting the reduction of staff administration costs to funnel funds into patient care. For example, Smart Triage is an AI-powered system deployed in UK GP practices that can triage patients making initial enquiries, and based on their responses, book them into the right care pathway, such as GP or nurse appointment, or referral to specialist clinician.
An evaluation of Smart Triage at a Surrey GP practice in 2024 showed the platform reduced the average patient waiting time by 73%.
For clinicians, especially GPs, iatroX is a UK-based AI clinical reference platform that helps doctors retrieve evidence-based clinical guidance, and summarising relevant literature & guidelines. Doctors in general practice are expected to be able to assess a full range of patientsβ needs, and such platforms help clinicians identify the cause of uncommon symptoms when GPs might lack specialist knowledge.
An evaluation in 2025 found a majority of surveyed users stating iatroX was useful (~86%) or reliable (~79%).
As documented by NHS England, AI platforms are used in practice, tackling tasks like diagnosis, the monitoring of chronic disease, provision of prescription advice, and handling general administration tasks that otherwise would take up cliniciansβ time. Of all the sectors where sensitive data has to be protected, medicine has one of the highest standards of governance, making the deployment of AI a delicate balance between operational effectiveness and the preservation of privacy.
(Image source: βDoctor appointmentβ by Taric25 is licensed under CC BY 2.0.)
Β

Want to learn more about AI and big data from industry leaders? Check out AI & Big Data Expo taking place in Amsterdam, California, and London. The comprehensive event is part of TechEx and co-located with other leading technology events. Click here for more information.
AI News is powered by TechForge Media. Explore other upcoming enterprise technology events and webinars here.
The post UK doctorsβ surgeries deploying AI in patient care appeared first on AI News.
The Missing Layer of AGI: From Pattern Alchemy to Coordination Physics
XR-DT: Extended Reality-Enhanced Digital Twin for Agentic Mobile Robots
Simulating Life Paths with Digital Twins: AI-Generated Future Selves Influence Decision-Making and Expand Human Choice
Optimizing Medical Question-Answering Systems: A Comparative Study of Fine-Tuned and Zero-Shot Large Language Models with RAG Framework
M4-RAG: A Massive-Scale Multilingual Multi-Cultural Multimodal RAG
ToolMind Technical Report: A Large-Scale, Reasoning-Enhanced Tool-Use Dataset
Self-Transparency Failures in Expert-Persona LLMs: How Instruction-Following Overrides Honesty
The AI Productivity Index (APEX)
Chinese Discharge Drug Recommendation in Metabolic Diseases with Large Language Models
Designing LLM-based Multi-Agent Systems for Software Engineering Tasks: Quality Attributes, Design Patterns and Rationale
Concept-Guided Backdoor Attack on Vision Language Models
Critical Appraisal Tools for Evaluating Artificial Intelligence in Clinical Studies: Scoping Review
Exploring a Digital Health Solution to Collect and Manage Health-Related Needs for Patients Who Undergo Complex Surgery: Mixed Methods Study
Molecular stratification of esophageal adenocarcinoma: implications for prognosis and treatment strategy
Oncogene, Published online: 08 December 2025; doi:10.1038/s41388-025-03650-3
Molecular stratification of esophageal adenocarcinoma: implications for prognosis and treatment strategyAI-driven transfer learning and classical molecular dynamics for strategic therapeutic repurposing and rational design of antiviral peptides targeting monkeypox virus DNA polymerase
Comput Biol Med. 2025 Dec 7;200:111372. doi: 10.1016/j.compbiomed.2025.111372. Online ahead of print.
ABSTRACT
The emergence of monkeypox virus (MPXV) as a global health threat has necessitated the rapid identification of novel antiviral therapeutics. Currently, no FDA-approved drugs are specifically designed against the disease. We used an in-house deep learning pharmacophore model for screening a library of 1974 FDA-approved drugs targeting the active site of MPXV DNA polymerase. Three drugs exhibited the strongest binding affinities, outperforming the control drug, Cidofovir diphosphate, and forming stable interactions with key active site residues. Among them, Paromomycin emerged as the most favourable drug, demonstrating stable, persistent, and adaptable interactions in molecular dynamics simulation. In parallel, we developed a novel automated peptide-generating AI pipeline that integrates active-site residues with knowledge-guided amino acid selection to generate and evaluate synthetic peptides. Cysteine-Phenylalanine-Cysteine (CFC), together with a panel of candidates, emerged through rational balancing of physicochemical properties and drug-likeness for accelerated therapeutic discovery. Synthetic peptides were evaluated to further understand the binding efficacies with DNA polymerase. CFC peptide demonstrated strong binding affinity (-8.08 kcal/mol) through stable interactions with key catalytic residues ASP549, ARG634 and LYS661, while MMGBSA analysis confirmed favourable binding energy (-33.02 kcal/mol). Consistent results in MD simulations indicate functional binding without destabilisation. Although ADMET predictions for CFC revealed limitations in permeability and oral bioavailability, its favourable binding profile and reduced predicted toxicity support its potential as a novel antiviral lead.
PMID:41360016 | DOI:10.1016/j.compbiomed.2025.111372
Explainable artificial intelligence and ensemble learning for hepatocellular carcinoma classification: State of the art, performance, and clinical implications
World J Hepatol. 2025 Nov 27;17(11):109494. doi: 10.4254/wjh.v17.i11.109494.
ABSTRACT
Hepatocellular carcinoma (HCC) remains a leading cause of cancer-related mortality globally, necessitating advanced diagnostic tools to improve early detection and personalized targeted therapy. This review synthesizes evidence on explainable ensemble learning approaches for HCC classification, emphasizing their integration with clinical workflows and multi-omics data. A systematic analysis [including datasets such as The Cancer Genome Atlas, Gene Expression Omnibus, and the Surveillance, Epidemiology, and End Results (SEER) datasets] revealed that explainable ensemble learning models achieve high diagnostic accuracy by combining clinical features, serum biomarkers such as alpha-fetoprotein, imaging features such as computed tomography and magnetic resonance imaging, and genomic data. For instance, SHapley Additive exPlanations (SHAP)-based random forests trained on NCBI GSE14520 microarray data (n = 445) achieved 96.53% accuracy, while stacking ensembles applied to the SEER program data (n = 1897) demonstrated an area under the receiver operating characteristic curve of 0.779 for mortality prediction. Despite promising results, challenges persist, including the computational costs of SHAP and local interpretable model-agnostic explanations analyses (e.g., TreeSHAP requiring distributed computing for metabolomics datasets) and dataset biases (e.g., SEER's Western population dominance limiting generalizability). Future research must address inter-cohort heterogeneity, standardize explainability metrics, and prioritize lightweight surrogate models for resource-limited settings. This review presents the potential of explainable ensemble learning frameworks to bridge the gap between predictive accuracy and clinical interpretability, though rigorous validation in independent, multi-center cohorts is critical for real-world deployment.
PMID:41358057 | PMC:PMC12679159 | DOI:10.4254/wjh.v17.i11.109494